Dyspnea in Post-Acute COVID-19: A Multi-Parametric Cardiopulmonary Evaluation
Journal of Clinical Medicine · 13.07.2023 · 12 (14) · 4658
DOI: 10.3390/jcm12144658 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.07.2023. Verfasst von Antonella Cecchetto und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padua, 35128 Padua, Italy. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Post-acute COVID-19 is characterized by the persistence of dyspnea, but the pathophysiology is unclear. We evaluated the prevalence of dyspnea during follow-up and factors at admission and follow-up associated with dyspnea persistence. After five months from discharge, 225 consecutive patients hospitalized for moderate to severe COVID-19 pneumonia were assessed clinically and by laboratory tests, echocardiography, six-minute walking test (6MWT), and pulmonary function tests. Fifty-one patients reported persistent dyspnea. C-reactive protein (p = 0.025, OR 1.01 (95% CI 1.00–1.02)) at admission, longer duration of hospitalization (p = 0.005, OR 1.05 (95% CI 1.01–1.10)) and higher body mass index (p = 0.001, OR 1.15 (95% CI 1.06–1.28)) were independent predictors of dyspnea. Absolute drop in SpO2 at 6MWT (p = 0.001, OR 1.37 (95% CI 1.13–1.69)), right ventricular (RV) global longitudinal strain (p = 0.016, OR 1.12 (95% CI 1.02–1.25)) and RV global longitudinal strain/systolic pulmonary artery pressure ratio (p = 0.034, OR 0.14 (95% CI 0.02–0.86)) were independently associated with post-acute COVID-19 dyspnea. In conclusion, dyspnea is present in many patients during follow-up after hospitalization for COVID-19 pneumonia. While higher body mass index, C-reactive protein at admission, and duration of hospitalization are predictors of persistent dyspnea, desaturation at 6MWT, and echocardiographic RV dysfunction are associated with this symptom during the follow-up period.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padua, 35128 Padua, Italy.
- Respiratory Pathophysiology Division, University of Padua, 35128 Padua, Italy.
ORCID-Profile: Antonella Cecchetto, Andrea Vianello, Chiara Palermo, Giulia Lorenzoni, Patrizia Bartolotta, Filippo Donato, Donato Mele
Zitieren
APA
Cecchetto, A., Guarnieri, G., Torreggiani, G., Vianello, A., Baroni, G., Palermo, C., Bertagna De Marchi, L., Lorenzoni, G., Bartolotta, P., Bertaglia, E., Donato, F., Aruta, P., Iliceto, S., & Mele, D. (2023). Dyspnea in Post-Acute COVID-19: A Multi-Parametric Cardiopulmonary Evaluation. Journal of Clinical Medicine, 12(14), 4658. https://doi.org/10.3390/jcm12144658
Vancouver
Cecchetto A, Guarnieri G, Torreggiani G, Vianello A, Baroni G, Palermo C, et al. Dyspnea in Post-Acute COVID-19: A Multi-Parametric Cardiopulmonary Evaluation. Journal of Clinical Medicine. 2023;12(14):4658. doi:10.3390/jcm12144658
BibTeX
@article{Cecchetto2023,
author = {Cecchetto, Antonella and Guarnieri, Gabriella and Torreggiani, Gianpaolo and Vianello, Andrea and Baroni, Giulia and Palermo, Chiara and Bertagna De Marchi, Leonardo and Lorenzoni, Giulia and Bartolotta, Patrizia and Bertaglia, Emanuele and Donato, Filippo and Aruta, Patrizia and Iliceto, Sabino and Mele, Donato},
title = {Dyspnea in Post-Acute COVID-19: A Multi-Parametric Cardiopulmonary Evaluation},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {14},
pages = {4658},
doi = {10.3390/jcm12144658}
}
EUVIMED